ESPID Guidelines
These guidelines are intended to support clinical decision-making but do not replace professional judgment. Individual patient circumstances, preferences and local practices must always be considered. The guidelines are advisory only and ESPID accepts no liability for outcomes arising from their use.
The Committee for Guidelines with ESPID Board approval have recently updated the process for ESPID guideline development:
Proposed Review Process for ESPID Guideline Development
Stage 1. Committee for Guidelines review
- The CfG reviews the guideline to ensure that it meets ESPID requirements for format, methodology and content.
Stage 2. ESPID member consultation
- ESPID members should have an opportunity to comment.
- The manuscript will not be placed on the website but will be available to ESPID members only on request.
- Members will be able to receive the guideline on the understanding and condition that:
- the document is kept confidential and not forwarded, shared or otherwise disseminated
- they will review and provide comments on the guideline and/or suggestions for amendment.
- Authors will be asked to respond to comments and amend the manuscript as appropriate.
- Ideally, for full transparency, comments and author responses from this stage will be published on the ESPID website.
- Handling disagreements with the guideline recommendations during consultation:
- If a significant dispute remains unresolved, the matter should return to the Guidelines Committee who will be the final arbiters.
- The Board could be consulted if a particularly significant or contentious issue cannot be resolved.
Stage 3. Expert peer review
- The guideline proceeds through the normal PIDJ peer-review process.
- Expert reviewers should be selected based primarily on expertise.
- Reviewers do not necessarily need to be ESPID members if a suitable expert is available outside the Society
Meet the Committee for Guidelines
